Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor H Engelhard

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Annals of Surgery|August 20, 2019
The Barrier Molecules Junction Plakoglobin, Filaggrin, and Dystonin Play Roles in Melanoma Growth and AngiogenesisKatie M Leick, Anthony B Rodriguez, Marit M Melssen, et al.
Frontiers in Immunology|May 7, 2019
Comparative Transcriptomic Analysis Identifies a Range of Immunologically Related Functional Elaborations of Lymph Node Associated Lymphatic and Blood Endothelial CellsStella J Berendam, Alexander F Koeppel, Nicole R Godfrey, et al.
Cancer Immunology Research|August 20, 2021
Characteristics of Immune Memory and Effector Activity to Cancer-Expressed MHC Class I Phosphopeptides Differ in Healthy Donors and Ovarian Cancer PatientsAmanda M Lulu, Kara L Cummings, Erin D Jeffery, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2009
Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapyFlorence R Depontieu, Jie Qian, Angela L Zarling, et al.
Theranostics|August 6, 2020
Immunomodulation of intracranial melanoma in response to blood-tumor barrier opening with focused ultrasoundColleen T Curley, Aaron D Stevens, Alexander S Mathew, et al.
British Journal of Haematology|November 18, 2003
Disparity for a newly identified minor histocompatibility antigen, HA-8, correlates with acute graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical siblingYoshiki Akatsuka, Edus H Warren, Ted A Gooley, et al.
Oncoimmunology|October 6, 2018
Formation and phenotypic characterization of CD49a, CD49b and CD103 expressing CD8 T cell populations in human metastatic melanomaMarit M Melssen, Walter Olson, Nolan A Wages, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
Tapasin is a facilitator, not an editor, of class I MHC peptide bindingAngela L Zarling, Chance John Luckey, Jarrod A Marto, et al.
Pigment Cell & Melanoma Research|June 18, 2014
Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentationJonathan M Eby, Hee-Kap Kang, Jared Klarquist, et al.
Cancer Immunology, Immunotherapy : CII|November 2, 2024
Differential T cell accumulation within intracranial and subcutaneous melanomas is associated with differences in intratumoral myeloid cellsKatarzyna Stasiak, Aaron D Stevens, Ashley C Bolte, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Annals of Surgery|August 20, 2019
The Barrier Molecules Junction Plakoglobin, Filaggrin, and Dystonin Play Roles in Melanoma Growth and AngiogenesisKatie M Leick, Anthony B Rodriguez, Marit M Melssen, et al.
Frontiers in Immunology|May 7, 2019
Comparative Transcriptomic Analysis Identifies a Range of Immunologically Related Functional Elaborations of Lymph Node Associated Lymphatic and Blood Endothelial CellsStella J Berendam, Alexander F Koeppel, Nicole R Godfrey, et al.
Cancer Immunology Research|August 20, 2021
Characteristics of Immune Memory and Effector Activity to Cancer-Expressed MHC Class I Phosphopeptides Differ in Healthy Donors and Ovarian Cancer PatientsAmanda M Lulu, Kara L Cummings, Erin D Jeffery, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2009
Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapyFlorence R Depontieu, Jie Qian, Angela L Zarling, et al.
Theranostics|August 6, 2020
Immunomodulation of intracranial melanoma in response to blood-tumor barrier opening with focused ultrasoundColleen T Curley, Aaron D Stevens, Alexander S Mathew, et al.
British Journal of Haematology|November 18, 2003
Disparity for a newly identified minor histocompatibility antigen, HA-8, correlates with acute graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical siblingYoshiki Akatsuka, Edus H Warren, Ted A Gooley, et al.
Oncoimmunology|October 6, 2018
Formation and phenotypic characterization of CD49a, CD49b and CD103 expressing CD8 T cell populations in human metastatic melanomaMarit M Melssen, Walter Olson, Nolan A Wages, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
Tapasin is a facilitator, not an editor, of class I MHC peptide bindingAngela L Zarling, Chance John Luckey, Jarrod A Marto, et al.
Pigment Cell & Melanoma Research|June 18, 2014
Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentationJonathan M Eby, Hee-Kap Kang, Jared Klarquist, et al.
Cancer Immunology, Immunotherapy : CII|November 2, 2024
Differential T cell accumulation within intracranial and subcutaneous melanomas is associated with differences in intratumoral myeloid cellsKatarzyna Stasiak, Aaron D Stevens, Ashley C Bolte, et al.
Pageof 9